BioCorRx(BICX)
$0.21-0.00 (-0.95%)
BICX
BioCorRx financials statements
$0.21
At close:-0.00 (-0.95%)
Want to see BICX full AI Analyst Report?
BioCorRx (BICX) Ratios
6 Followers
BioCorRx Ratios
BICX's free cash flow for Q3 2026 was $-179.62K. For the 2026 fiscal year, BICX's free cash flow was increased by $0.00 and operating cash flow was $-179.62K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.10 | 0.01 | 0.03 | 0.06 | 0.05 |
| Quick Ratio | 0.08 | 0.01 | 0.03 | 0.06 | 0.05 |
| Cash Ratio | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 |
| Solvency Ratio | -0.25 | -0.39 | -0.34 | -0.47 | -0.72 |
| Operating Cash Flow Ratio | -0.28 | -0.13 | -0.29 | -0.38 | -0.81 |
| Short-Term Operating Cash Flow Coverage | -1.21 | -0.43 | -1.15 | -1.44 | -3.04 |
| Net Current Asset Value | $ -12.86M | $ -12.62M | $ -10.15M | $ -8.65M | $ -7.55M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.99 | 7.27 | 4.66 | 2.19 | 2.16 |
| Debt-to-Equity Ratio | -0.19 | -0.23 | -0.18 | -0.21 | -0.26 |
| Debt-to-Capital Ratio | -0.23 | -0.30 | -0.23 | -0.26 | -0.35 |
| Long-Term Debt-to-Capital Ratio | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
| Financial Leverage Ratio | -0.19 | -0.03 | -0.04 | -0.09 | -0.12 |
| Debt Service Coverage Ratio | -0.92 | -0.88 | -1.08 | -1.25 | -2.59 |
| Interest Coverage Ratio | -5.61 | -3.35 | -4.27 | -2.68 | -8.01 |
| Debt to Market Cap | 0.37 | 0.66 | 0.26 | 0.21 | 0.05 |
| Interest Debt Per Share | 0.16 | 0.41 | 0.32 | 0.38 | 0.36 |
| Net Debt to EBITDA | -0.76 | -0.76 | -0.65 | -0.51 | -0.38 |
| Profitability Margins | |||||
| Gross Profit Margin | 86.72% | 78.25% | 59.64% | 92.85% | 87.82% |
| EBIT Margin | -332.04% | -48069.78% | -3234.48% | -1538.55% | -9622.46% |
| EBITDA Margin | -326.53% | -46827.16% | -3010.23% | -1472.17% | -9272.48% |
| Operating Profit Margin | -606.04% | -66829.81% | -4248.31% | -1360.12% | -9389.92% |
| Pretax Profit Margin | -440.11% | -67998.72% | -4228.90% | -2046.77% | -10794.33% |
| Net Profit Margin | -431.50% | -66616.10% | -4224.89% | -2043.30% | -12021.81% |
| Continuous Operations Profit Margin | -431.50% | -67998.72% | -4228.90% | -2046.77% | -10794.33% |
| Net Income Per EBT | 98.04% | 97.97% | 99.91% | 99.83% | 111.37% |
| EBT Per EBIT | 72.62% | 101.75% | 99.54% | 150.48% | 114.96% |
| Return on Assets (ROA) | -160.21% | -1323.03% | -968.64% | -569.98% | -707.72% |
| Return on Equity (ROE) | 30.65% | 42.13% | 38.35% | 54.10% | 84.80% |
| Return on Capital Employed (ROCE) | 78.45% | 65.49% | 62.69% | 63.27% | 127.09% |
| Return on Invested Capital (ROIC) | 112.37% | 97.66% | 87.81% | 95.67% | 198.47% |
| Return on Tangible Assets | -337.40% | -1350.49% | -991.66% | -616.79% | -762.96% |
| Earnings Yield | -63.93% | -128.41% | -57.88% | -62.26% | -20.65% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.61 | 0.00 | 1.16 | 1.29 | 0.83 |
| Payables Turnover | 0.03 | 0.00 | 0.01 | 0.01 | 0.00 |
| Inventory Turnover | 0.74 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 196.27 | 0.04 | 0.60 | 0.62 | 0.10 |
| Asset Turnover | 0.37 | 0.02 | 0.23 | 0.28 | 0.06 |
| Working Capital Turnover Ratio | -0.10 | -0.00 | -0.02 | -0.05 | -0.02 |
| Cash Conversion Cycle | -13256.40 | -662017.82 | -24772.62 | -47811.99 | -109844.83 |
| Days of Sales Outstanding | 139.86 | 0.00 | 315.24 | 282.54 | 437.49 |
| Days of Inventory Outstanding | 494.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 13890.78 | 662017.82 | 25087.86 | 48094.53 | 110282.32 |
| Operating Cycle | 634.38 | 0.00 | 315.24 | 282.54 | 437.49 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.12 | -0.10 | -0.22 | -0.28 | -0.55 |
| Free Cash Flow Per Share | -0.12 | -0.10 | -0.22 | -0.28 | -0.55 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -926641.00 | 0.00 | -70.76 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -926641.00 | 0.00 | -70.76 |
| Operating Cash Flow Coverage Ratio | -1.08 | -0.39 | -1.02 | -1.22 | -2.00 |
| Operating Cash Flow to Sales Ratio | -2.88 | -143.02 | -20.79 | -9.55 | -73.29 |
| Free Cash Flow Yield | -42.71% | -27.57% | -28.48% | -29.09% | -12.76% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.53 | -0.78 | -1.73 | -1.61 | -4.84 |
| Price-to-Sales (P/S) Ratio | 6.75 | 518.78 | 73.00 | 32.82 | 582.25 |
| Price-to-Book (P/B) Ratio | -0.48 | -0.33 | -0.66 | -0.87 | -4.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.34 | -3.63 | -3.51 | -3.44 | -7.83 |
| Price-to-Operating Cash Flow Ratio | -2.34 | -3.63 | -3.51 | -3.44 | -7.94 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | -0.09 | 0.07 | 0.05 | -0.26 |
| Enterprise Value Multiple | -2.83 | -1.87 | -3.08 | -2.74 | -6.66 |
| Enterprise Value | 7.37M | 6.69M | 8.26M | 8.63M | 29.79M |
| EV to EBITDA | -2.83 | -1.87 | -3.08 | -2.74 | -6.66 |
| EV to Sales | 9.25 | 873.42 | 92.59 | 40.35 | 617.19 |
| EV to Free Cash Flow | -3.21 | -6.11 | -4.45 | -4.23 | -8.30 |
| EV to Operating Cash Flow | -3.21 | -6.11 | -4.45 | -4.23 | -8.42 |
| Tangible Book Value Per Share | -0.68 | -1.18 | -1.19 | -1.15 | -1.08 |
| Shareholders’ Equity Per Share | -0.61 | -1.16 | -1.18 | -1.12 | -1.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.04 | 0.00 | 0.01 | 0.03 | 0.01 |
| Net Income Per Share | -0.19 | -0.49 | -0.45 | -0.61 | -0.89 |
| Tax Burden | 0.98 | 0.98 | 1.00 | 1.00 | 1.11 |
| Interest Burden | 1.33 | 1.41 | 1.31 | 1.33 | 1.12 |
| Research & Development to Revenue | 2.22 | 193.46 | 9.99 | 6.82 | 33.27 |
| SG&A to Revenue | 4.76 | 471.30 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.74 | 159.07 | 3.11 | 1.66 | 4.34 |
| Income Quality | 0.66 | 0.21 | 0.49 | 0.47 | 0.68 |
Currency in USD

